Pharmacy Times Continuing Education
What Comes Next? A Case-Based Approach to Sequencing HR+/HER2–Metastatic Breast Cancer. A continuing education activity offered by Pharmacy Times Continuing Education.
Before you enroll
What Comes Next? A Case-Based Approach to Sequencing HR+/HER2–Metastatic Breast Cancer is offered by Pharmacy Times Continuing Education for pharmacists. Topics in this listing: Pharmacology.
Check the credit type and approval notes below against your credential. The provider handles enrollment, completion and the certificate.
Provider-stated credit; confirm acceptance for your license and jurisdiction.
Listed roles: Pharmacist
Approval / program ID: 0290-0000-26-242-H01-P
State scope: No individual state acceptance claim is made in this listing.
ACPEThe provider identifies this activity as free continuing education. Complete the stated assessment and claiming requirements.
The recorded cost is $0 for learning, assessment and the certificate, with no separate reporting fee identified. Pharmacy Times Continuing Education requires a free account. The provider identifies this activity as free continuing education. Complete the stated assessment and claiming requirements.
The provider lists 1.25 ACPE CPE. Recorded roles: Pharmacist. Match the individual track below to your credential and board before enrolling.
This is an on-demand activity in the current collection; follow the source link to begin. The recorded credit expiration date is 2027-07-31.
Create a free PTCE account and complete the activity in its entirety. Complete the pretest, posttest and evaluation as required, then request CPE Monitor credit before the activity expires. Completion and certificate delivery are handled by Pharmacy Times Continuing Education; saving this listing does not enroll you or claim credit.
These are the primary pages supporting this listing. Course recognition and board acceptance should be confirmed for your credential before enrollment.
Your next credential
Preparing for an exam, too? Explore free practice questions and explanations on OpenExamPrep.
OpenExamPrepFree exam preparationThese are exam-preparation resources, separate from continuing education credit. Exam registration fees and eligibility are set by the exam sponsor.
The Next Frontier: Strategic Sequencing and Biomarker-Driven Therapy in HR+ Metastatic Breast Cancer. A continuing education activity offered by Pharmacy Times Continuing Education.
Pipeline to Practice in Platinum-Resistant Ovarian Cancer: What's New, What's Next, and How to Prepare. A continuing education activity offered by Pharmacy Times Continuing Education.
Bridging Innovation and Access in HR-Positive/HER2-Negative Metastatic Breast Cancer: Implications for Managed Care. A continuing education activity offered by Pharmacy Times Continuing Education.
